Pharmacogenetic testing for warfarin dosage helps personalise treatment with warfarin, a commonly prescribed blood thinner used to prevent clot formation in conditions such as atrial fibrillation and after certain surgeries. Warfarin has a narrow therapeutic window, and incorrect dosing can lead to life-threatening bleeding or ineffective clot prevention. This test analyses genetic variations in the CYP2C9 and VKORC1 genes to help determine the ideal warfarin dose, ensuring safer and more effective treatment.
Home / Tests Services / Pharmacogenomics
Pharmacogenomics · Sanger Sequencing
Warfarin Mutation Testing
CYP2C9 and VKORC1 variants for safer anticoagulant dosing.
Drop a photo for this test
or browse files
Overview
This test is offered for informational and preventive-health purposes. Results should be interpreted by a qualified healthcare professional alongside your clinical history, and do not by themselves constitute a medical diagnosis.
TEST DETAILS
Warfarin Mutation Testing
| Method | Sanger Sequencing |
|---|---|
| Genes Analysed | CYP2C9 and VKORC1 |
| Sample Type | Blood |
| Container | EDTA Tube |
| Sample Quantity | 3–5 mL |
| Turnaround Time | 7 Days |
Expert result consultation included
Related tests.
View all 13 tests →Book a test
Request a callback.
Our clinical nutrition team will confirm suitability, explain sample collection, and book your slot.
✉
EMAIL
☎
PHONE
📍
VISIT
Flat No. 02, Shivam Apartment, Behind New Era English School, Govind Nagar, Nashik, MH-422009
We reply within one working day. Your details stay confidential.
Diagnostic testing is offered for informational and preventive-health purposes and does not constitute medical diagnosis or treatment. Always consult a qualified healthcare professional before making clinical decisions.